Annual Report

Overview

The report highlights Rua Bioscience's strong FY25 commercial growth, with total revenue and other income reaching $1.9m and products expanding across international markets. It describes the Compassionate Access Programme's expansion to support up to 52 patients, alongside scholarships and other local impact initiatives. The company also completed its fourth year of GHG measuring and reporting, with FY25 total emissions reported at 2079 tCO2-e.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: Ends 30 June 2025
Publication date: 29 September 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services